Skip to main content
. 2022 Nov 17;15:84. doi: 10.1186/s40545-022-00490-4

Table 4.

The rates of antibiotics consumption by ward types, patient demographics, the purpose of use, and types of antibiotics used among hospitalized adult patients at JMC (n = 360)

Variables Sum of DOT (%) Sum of BD DOT/100BD
Wards JMC
 Medical 3266 (61.1) 2702 120.9
 Surgical 1359 (24.5) 1293 105.1
 GYN/OBS 912 (16.4) 993 91.8
Sex of the patients
 Male 3024 (54.6) 2437 124.1
 Female 2513 (45.4) 2551 98.5
WHO standard age group
 18–47 years old (young group) 4021 (72.6) 3454 116.4
 48–63 years old (middle age group) 1021 (18.4) 1022 99.9
 ≥ 64 years old (elderly group) 495 (9.0) 512 96.7
Antibiotics use purposes
 Prophylaxis 319 (5.8) 703 45.4
 Treatment 3814 (68.9) 3243 117.6
 Both prophylaxis and treatment 1404 (25.3) 1042 134.7
Rates of antibiotics utilization in JMC during the study duration
Overall days of therapy and bed-days (denominators) 5537 (100.0) 4988 111DOT/100BD
Penicillins
 Ampicillin, amoxicillin, and cloxacillin 766 (13.8) The common denominator (4988) 15.36
Cephalosporins
 Cephalexin, ceftriaxone, and ceftazidime 5982 (108) 119.93
Macrolides
 Azithromycin and clarithromycin 508 (9.2) 10.18
Fluoroquinolones
 Ciprofloxacin and norfloxacin 632 (11.4) 12.67
Augmentin
 Amoxicillin–clavulanic acid 130 (2.3) 2.61
Cotrimoxazole
 Trimethoprim–sulfonamide 646 (11.7) 12.95
Tetracyclines
 Doxycycline 284 (5.1) 5.69
Aminoglycosides
 Gentamicin 84 (1.5) 1.68
Nitro-imidazole
 Metronidazole 2699 (48.7) 54.11
Carbapenems
 Meropenem 111 (2.0) 2.23
Glycopeptides
 Vancomycin 1970 (35.6) 49.49
Others
 Other antibiotics* 174 (3.1) 3.48
Mean ± standard deviation (Range) 15.4 ± 14.4 (1–90) 13.9 ± 9.0 (1–67)

*Benzathine penicillin and erythromycin